PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-28.46%
Both yoy net incomes decline, with AVGO at -9.78%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-6.14%
Both reduce yoy D&A, with AVGO at -0.37%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-109.77%
Negative yoy deferred tax while AVGO stands at 17.96%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-276.09%
Negative yoy working capital usage while AVGO is 18.76%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-1590.91%
Negative yoy inventory while AVGO is 26.35%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-94.80%
Negative yoy usage while AVGO is 68.61%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.00%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-63.17%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-46.89%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
6.95%
Less growth in investment purchases vs. AVGO's 45.71%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-22.49%
We reduce yoy sales while AVGO is 333.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
131.82%
We have some outflow growth while AVGO is negative at -176.92%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-271.30%
We reduce yoy invests while AVGO stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-45.45%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-49.57%
Both yoy lines negative, with AVGO at -107.07%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.